This study represents one of the first evidence for signaling of PrPC via RPSA with the engagement of downstream Erk1/2, PI3K/Akt and FAK signaling pathways to control survival, proliferation and cell–matrix–adhesion in schwannoma cells, suggesting PrPC and its interactor as potential therapeutic targets for schwannomas. This evidence concerns the gene AKT1 and schwannoma.